Proclara Biosciences
develops and commercializes fusion-protein drug therapies for the treatment of chronic neurodegenerative diseases... Read moreProclara Biosciences
develops and commercializes fusion-protein drug therapies for the treatment of chronic neurodegenerative diseases... Read more
CEO
Add
News
Jul 26, 2018
BioPortfolio
Proclara Biosciences: Proclara Biosciences Announces Initiation of NPT189 Clinical Development for Systemic Amyloidoses and Provides Pipeline Update
Mar 28, 2018
BioPortfolio
Proclara Biosciences: Proclara Biosciences Presents Preclinical Data Supporting the Development of GAIMBased Therapies for Peripheral Amyloidoses at the 16th International Symposium on Amyloidosis
Mar 06, 2018
PharmiWeb
Proclara Biosciences: Proclara Biosciences to Present at the Cowen and Company 38th Annual Health Care Conference
Jan 04, 2018
BORDERLESS FOR LEADERS
Proclara Biosciences: Proclara nabs Merck Alzheimer's R&D executive
Nov 14, 2017
PharmiWeb
Proclara Biosciences: Proclara Biosciences Presents New Preclinical Data Supporting Development of GAIM-Based Therapies at Society for Neuroscience Annual Meeting
Nov 07, 2017
PharmiWeb
Proclara Biosciences: Proclara Biosciences to Present at the Stifel 2017 Healthcare Conference
Jul 18, 2017
BioSpace
Proclara Biosciences: Proclara Presents New Preclinical Data Supporting The Development Of NPT189 At
Jul 17, 2017
BioSpace
Proclara Biosciences: Proclara Announces Pipeline Progress
Apr 26, 2017
BioSpace
Proclara Biosciences: Exec Who Orchestrated Promedior's $1.25 Billion Buyout Deal From Bristol-Myers Squibb to Helm Proclara
Mar 10, 2017
Genetic Engineering & Biotechnology News
Proclara Biosciences: Proclara Wins $250K BPA Grant to Develop AD Drug Targeting Protein Misfolding
Proclara Biosciences Competitors
1
2
3
4
5
6
7
8
9
10